The Use of Antioxidants in Transmissible Spongiform Encephalopathies: A Case Report

Journal of the American College of Nutrition

Volumn 21, Issue 1, 2002, Pages 22-25

  Drisko, Jeanne A ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Brain inflammation; Neurodegeneration; Oxidative stress; Prion; Transmissible spongiform encephalopathies

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

AGED; ARTICLE; CASE REPORT; CELL VACUOLE; CHROMOSOME ABERRATION; ENCEPHALITIS; FEMALE; GLIOSIS; HUMAN; IMMUNE SYSTEM; INFLAMMATORY CELL; NERVE DEGENERATION; NEUROPIL; OXIDATIVE STRESS; PATHOGENESIS; PRION DISEASE;

AGED; ANTIOXIDANTS; CREUTZFELDT-JAKOB SYNDROME; DEMENTIA; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HUMANS; PRION DISEASES; REACTIVE OXYGEN SPECIES;

EID: 0036161564     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2002.10719189     Document Type: Article

References (38)

1. Prusiner SB: Molecular biology of prion disease. Science 252: 1515-1522, 1991.
2. Liberski PP, Yanagihara R, Nerurkar V, Gajdusek DC: Further ultrastructural studies of lesions produced in the optic nerve by tumor necrosis factor : a comparison with experimental Creutzfeldt-Jakob disease. Acta Neurobiol Exp 54: 209-218, 1994.
3. Brown DR, Schmidt B, Kretzschmar HA: A prion protein fragment primes type 1 astrocytes to proliferation signals from microglia. Neurobiol Diseases 4: 410-422, 1998.
4. Prusiner SB: Prions. Proc Natl Acad Sci USA 95: 13363-13383, 1998.
5. Collinge J: Variant Creutzfeldt-Jakob disease. Lancet 354: 317-323, 1999.
6. Prusiner SB: Biology and genetics of prion diseases. Annu Rev Microbiol 48: 655-686, 1994.
7. Baker CA, Lu ZY, Zaitsev I, Manuelidis L: Microglial activation varies in different models of Creutzfeldt-Jakob disease. J Virol 73: 5089-5097, 1999.
8. Bastian FO, Hart MN, Cancilla PA: Additional evidence of spiroplasma in Creutzfeldt-Jakob disease. Lancet: 660, 1981.
9. Bastian FO, Purnell DM, Tully JG: Neuropathology of spiroplasma infection in the rat brain. Am J Pathol 114: 496-514, 1984.
10. Bastian FO, Jennings RA, Gardner WA: Antiserum to scrapieassociated fibril protein cross-reacts with Spiroplasma mirum fibril proteins. J Clin Microbiology 25: 2430-2431, 1987.
11. Bastian FO, Foster JW: Spiroplasma sp. 16SrDNA in Creutzfeldt Jakob disease and scrapie as shown by PCR and DNA sequence analysis. J Neuropathol Exp Neurol 60: 613-620, 2001.
12. Humprey-Smith I, Chastel C, Le Goff F: Spiroplasma and spongiform encephalopathies. Med J Aust 156: 142, 1992.
13. Manuelidis L: The dimensions of Creutzfeldt-Jakob disease. Transfusions 34: 915-928, 1994.
14. Manuelidis L: Vaccination with an attenuated Creutzfeldt-Jakob disease strain prevents expression of a virulent agent. Proc Natl Acad Sci USA 95: 2520-2525, 1998.
15. Manuelidis L, Sklaviadis T, Akowitz A, Fritch W: Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease. Proc Natl Acad Sci USA 92: 5124-5128, 1995.
16. Sharief MK, Green A, Dick JPR, Gawler J, Thompson EJ: Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt-Jakob disease. Neurology 52: 1289-1291, 1999.
17. McGeer EG, McGeer PL: Inflammation cytokines in the CNS: Possible role in the pathogenesis of neurodegeneration disorders and therapeutic implications. CNS Drugs 7: 214-228, 1997.
18. Lee DW, Sohn HO, Lim HB, Lee YG, Kim YS: Alteration of free radical metabolism in the brain of mice infected with scrapie agent. Free Rad Res 30: 499-507, 1999.
19. Balentine JD: Chapter 6: The nervous system. In “Pathology of Oxygen Toxicity.” New York: Academic Press, Harcourt Brace Publishers, 1982.
20. Guentchev M, Voigtlander T, Haberler C, Groschup MH, Budka H: Evidence for oxidative stress in human prion disease. Neurobiol Dis 7: 270-273, 2000.
21. Service RF: Pacific chemists throw switches, strike at disease: Alzheimer’s suspect. Science 291: 427, 2001.
22. Prasad KN, Hovland AR, Cole WC, Prasad KC, Nahreini P, Edwards-Prasad J, Andreatta CP: Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale. Clin Neuropharmocol 23: 2-13, 2000.
23. Beringue V, Demoy M, Lasmezas CI, Gouritin B, Weingarten C, Deslys JP, Andreux JP, Couvreur P, Dormont D: Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis. J Pathol 190: 495-502, 2000.
24. Prusiner SB: The prion diseases. Sci Am 272: 30-37, 1995.
25. Manuelidis L, Fritch W, Xi YG: Evolution of a strain of CJD that induces BSE-like plaques. Science 277: 94-98, 1997.
26. Hsueh W, Tan X, Sun X, Gonzalez-Crussi F: Interaction of inflammatory cytokines, bacterial products, and lipid mediators in intestinal injury. In Remick and Friedland (eds): “Cytokine in Health and Disease,” 2nd ed. New York: Marcel Dekker, Inc. pp 432-443, 1997.
27. Hartmann G, Endres S: n-3 Polyunsaturated fatty acids and human cytokine synthesis. In Yehuda S, Mostofsky DI (eds): “Handbook of Essential Fatty Acid Biology.” Totowa, NJ: Humana Press, pp 103-113, 1997.
28. Delves PJ, Roitt IM: Advances in immunology: the immune system, first of two parts. N Engl J Med 343: 37-49, 2000.
29. Brown DR, Schmidt B, Kretzschmar HA: Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380: 345-347, 1996.
30. Brown DR, Schulz-Schaeffer WJ, Schmidt B, Kretzschmar HA: Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol 146: 104-112, 1997.
31. Manuelidis L, Fritch W, Zaitsev I: Dapsone to delay symptoms in Creutzfeldt-Jakob disease. Lancet 352: 456, 1998.
32. Delves PJ, Roitt IM: Advances in immunology: the immune system, second of two parts. N Engl J Med 343: 108-117, 2000.
33. Saas P, Boucraut J, Quiquerez AL, Schnuriger V, Perrin G, Desplat-Jego S, Bernard D, Walker PR, Dietrich PY: CD95 (Fas/ Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation? J Immunol 162: 2326-2333, 1999.
34. Roikhel VM, Fokina GI, Sobolev SG, Korolyev MB, Pogodina VV: Effect of hyperbaric oxygenation on experimental scrapie in mice. Acta Virol 28: 294-9, 1984.
35. Bastian FO, Jennings RA, Hoff CJ: Effect of trimethoprim/ sulphamethoxazole and hyperbaric oxygen on experimental Spiroplasma mirum encephalitis. Res Microbiol 140: 151-158, 1989.
36. Chavko M, Harabin AL: Regional lipid peroxidation and protein oxidation in rat brain after hyperbaric oxygen exposure. Free Radic Biol Med 20: 973-978, 1996.
37. Elayan IM, Axley MJ, Prasad PV, Ahlers ST, Auker CR: Effect of hyperbaric oxygen treatment on nitric oxide and oxygen free radicals in rat brain. J Neurophysiol 83: 2022-2029, 2000.
38. Djurhuus R, Svardal AM, Thorsen E: Glutathione in the cellular defense of human cells exposed to hyperoxia and high pressure. Undersea Hyperb Med 26: 75-85, 1999.